In summary, our results suggest CXCL-8 is a direct determinant of aggressive melanoma phenotypes, including tumor growth, metastasis, and angiogenesis, and targeting CXCL-8 produced by tumor cells and the supporting stroma is a direction for studying this pathway to develop future melanoma diagnosis and therapies. Here, CXCL8 is linked to neoplasm.